Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression.
Chien-Chih ChenToshiaki NakanoLi-Wen HsuChia Yi ChuKuang-Tzu HuangPublished in: Neuropsychiatric disease and treatment (2022)
Together, our findings suggest a complicated link between olanzapine therapy and metabolic disturbance and may garner interest in assessing the action of antipsychotic-induced metabolic disturbances.